Pi-Bansa, Sellase
Osei, Joseph Harold Nyarko
Frempong, Kwadwo Kyeremeh
Elhassan, Elizabeth
Akuoko, Osei Kweku
Agyemang, David
Ahorlu, Collins
Appawu, Maxwell Alexander
Koudou, Benjamin Guibehi
Wilson, Michael David
de Souza, Dziedzom Komi
Dadzie, Samuel Kweku
Utzinger, Jürg
Boakye, Daniel Adjei
Funding for this research was provided by:
Sightsavers International, Ghana
Liverpool School of Tropical Medicine
Article History
Received: 1 August 2018
Accepted: 17 January 2019
First Online: 5 February 2019
Ethics approval and consent to participate
: This study was approved by the institutional review board of the Noguchi Memorial Institute for Medical Research (Accra, Ghana; reference no. CPN 077/13–14) and the institutional research commission of the Swiss Tropical and Public Health Institute (Basel, Switzerland; reference no. FK 122a). All CVCs consented verbally to participate in the study. Albendazole and ivermectin were administered to CVCs before mosquito sampling commenced. Arrangement was also made with the nurses at the community-based health planning and services (CHPS) compound to provide treatment for CVCs who reported at their facility and tested positive for malaria.
: Not applicable.
: The authors declare that they have no competing interests.